Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Trotta

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Immunity|May 21, 2015
IL-2: Change Structure … Change FunctionJeffrey A Bluestone, Natasha Crellin, Eleonora Trotta
Expert Opinion on Therapeutic Targets|April 18, 2015
The therapeutic potential of regulatory T cells for the treatment of autoimmune diseaseJeffrey A Bluestone, Eleonora Trotta, Daqi Xu
Science Immunology|July 8, 2018
Revisiting IL-2: Biology and therapeutic prospectsAbul K Abbas, Eleonora Trotta, Dimitre R Simeonov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2018
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease TherapyJamie B Spangler, Eleonora Trotta, Jakub Tomala, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 2012
Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancyClaudia Carlino, Eleonora Trotta, Helena Stabile, et al.
Nature Medicine|June 27, 2018
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanismEleonora Trotta, Paul H Bessette, Stephanie L Silveria, et al.
Science (New York, N.Y.)|March 3, 2018
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexesJonathan T Sockolosky, Eleonora Trotta, Giulia Parisi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Immunity|May 21, 2015
IL-2: Change Structure … Change FunctionJeffrey A Bluestone, Natasha Crellin, Eleonora Trotta
Expert Opinion on Therapeutic Targets|April 18, 2015
The therapeutic potential of regulatory T cells for the treatment of autoimmune diseaseJeffrey A Bluestone, Eleonora Trotta, Daqi Xu
Science Immunology|July 8, 2018
Revisiting IL-2: Biology and therapeutic prospectsAbul K Abbas, Eleonora Trotta, Dimitre R Simeonov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2018
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease TherapyJamie B Spangler, Eleonora Trotta, Jakub Tomala, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 2012
Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancyClaudia Carlino, Eleonora Trotta, Helena Stabile, et al.
Nature Medicine|June 27, 2018
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanismEleonora Trotta, Paul H Bessette, Stephanie L Silveria, et al.
Science (New York, N.Y.)|March 3, 2018
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexesJonathan T Sockolosky, Eleonora Trotta, Giulia Parisi, et al.
Pageof 1